Emalex Biosciences, LLC is a biopharmaceutical company dedicated to the development of new treatments for rare and orphan neurological conditions. Ecopipam, its first development candidate, is a novel compound that has been studied as a potential treatment for many central nervous system (CNS) disorders, including pediatric Tourette Syndrome.

Biotechnology

Emalex Biosciences

Eric Messner

Jose Zapata

Trish Rice

Sarah Atkinson

Paul Reinfelds

Doug Frandsen

Christine H. Soulje

Frederick Munschauer

Tom Stothoff

Jenny Swalec

Jay White

The leadership team at Emalex Biosciences has a history of working in various pharmaceutical companies in project management, clinical study management, regulatory affairs, and clinical operations. They have also been educated in various fields such as international business management, psychology, biology, chemistry, and more.

Leadership Team

CEO and Executive Team

Founding Team

Leadership Team

About

Team members

Other teams at Emalex Biosciences

CEO and Executive Team

Founding Team